State-of-the-art considerations in small cell lung cancer brain metastases

Rimas V. Lukas; Vinai Gondi; David O. Kamson; Priya Kumthekar; Ravi Salgia

doi:10.18632/oncotarget.19333

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

State-of-the-art considerations in small cell lung cancer brain metastases

Rimas V. Lukas _, Vinai Gondi, David O. Kamson, Priya Kumthekar and Ravi Salgia

PDF | HTML | How to cite

Oncotarget. 2017; 8:71223-71233. https://doi.org/10.18632/oncotarget.19333

Metrics: PDF 1876 views | HTML 4715 views | ?

Abstract

Rimas V. Lukas1, Vinai Gondi2, David O. Kamson3, Priya Kumthekar1 and Ravi Salgia4

1Department of Neurology, Northwestern University, Chicago, IL, USA

2Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville, Northwestern Medicine Chicago Proton Center, Northwestern University, Warrenville, IL, USA

3Department of Neurology, University of Chicago, Chicago, IL, USA

4Department of Medical Oncology and Therapeutics, City of Hope, Duarte, CA, USA

Correspondence to:

Rimas V. Lukas, email: [email protected]

Keywords: brain metastases, chemotherapy, pathophysiology, radiation therapy, small cell lung cancer

Received: May 18, 2017 Accepted: July 03, 2017 Published: July 18, 2017

ABSTRACT

Background: Small cell lung cancer (SCLC) frequently leads to development of brain metastases. These unfortunately continue to be associated with short survival. Substantial advances have been made in our understanding of the underlying biology of disease. This understanding on the background of previously evaluated and currently utilized therapeutic treatments can help guide the next steps in investigations into this disease with the potential to influence future treatments.

Design: A comprehensive review of the literature covering epidemiology, pathophysiology, imaging characteristics, prognosis, and therapeutic management of SCLC brain metastases was performed.

Results: SCLC brain metastases continue to have a poor prognosis. Both unique aspects of SCLC brain metastases as well as features seen more universally across other solid tumor brain metastases are discussed. Systemic therapeutic studies and radiotherapeutic approaches are reviewed.

Conclusions: A clearer understanding of SCLC brain metastases will help lay the framework for studies which will hopefully translate into meaningful therapeutic options for these patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19333

Publication Alerts

Reviews:

State-of-the-art considerations in small cell lung cancer brain metastases

Abstract